Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3750)
All Articles published online
|
Jun 28, 2010 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Donadon V, Balbi M, Valent F, Avogaro A. Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol 2010; 16(24): 3025-3032 [PMID: 20572306 DOI: 10.3748/wjg.v16.i24.3025] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i24/3025.htm |
| Number | Citing Articles |
| 1 |
A. Al Qahtani, J.M.P. Holly, C.M. Perks. The Role of 5' Adenosine Monophosphate-Activated Protein Kinase in the Chemo-Sensitivity and Metabolic Behaviour of Breast Cancer Cells Exposed to Hypoxia and Hyperglycaemia. Journal of Cancer Research Updates 2022; 11: 6 doi: 10.30683/1929-2279.2022.11.02
|
| 2 |
Chiara Giordanino, Simone Ceretto, Simona Bo, Antonina Smedile, Alessia Ciancio, Elisabetta Bugianesi, Rinaldo Pellicano, Sharmila Fagoonee, Elisabetta Versino, Giuseppe Costa, Daniele Arese, Marco Sacco, Mario Rizzetto, Giorgio Saracco. Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study. Digestive and Liver Disease 2012; 44(5): 406 doi: 10.1016/j.dld.2011.12.003
|
| 3 |
Bindiya Thakkar, Konstantinos N. Aronis, Maria T. Vamvini, Kelsey Shields, Christos S. Mantzoros. Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies. Metabolism 2013; 62(7): 922 doi: 10.1016/j.metabol.2013.01.014
|
| 4 |
Alessia Ciancio, Roberta Bosio, Simona Bo, Marianna Pellegrini, Marco Sacco, Edoardo Vogliotti, Giulia Fassio, Andrea G. F. Bianco Mauthe Degerfeld, Monica Gallo, Chiara Giordanino, Lodovico Terzi di Bergamo, Davide Ribaldone, Elisabetta Bugianesi, Antonina Smedile, Mario Rizzetto, Giorgio Maria Saracco. Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct‐acting antiviral agents. Journal of Medical Virology 2018; 90(2): 320 doi: 10.1002/jmv.24954
|
| 5 |
Samy L. Habib, Maciej Rojna. Diabetes and Risk of Cancer. ISRN Oncology 2013; 2013: 1 doi: 10.1155/2013/583786
|
| 6 |
Austin Y. Feng, Alejandro Enriquez-Marulanda, Ali Kouhi, Noor-E-Seher Ali, Justin M. Moore, Yona Vaisbuch. Metformin Potential Impact on the Growth of Vestibular Schwannomas. Otology & Neurotology 2020; 41(3): 403 doi: 10.1097/MAO.0000000000002545
|
| 7 |
Saman Bahrambeigi, Vahid Shafiei-Irannejad. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin. Biochemical Pharmacology 2020; 174: 113787 doi: 10.1016/j.bcp.2019.113787
|
| 8 |
Hui Zhang, Chun Gao, Long Fang, Hong-Chuan Zhao, Shu-Kun Yao. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scandinavian Journal of Gastroenterology 2013; 48(1): 78 doi: 10.3109/00365521.2012.719926
|
| 9 |
S. Schlesinger, K. Aleksandrova, T. Pischon, M. Jenab, V. Fedirko, E. Trepo, K. Overvad, N. Roswall, A. Tjønneland, M.C. Boutron-Ruault, G. Fagherazzi, A. Racine, R. Kaaks, V.A. Grote, H. Boeing, A. Trichopoulou, M. Pantzalis, M. Kritikou, A. Mattiello, S. Sieri, C. Sacerdote, D. Palli, R. Tumino, P.H. Peeters, H.B. Bueno-de-Mesquita, E. Weiderpass, J.R. Quirós, R. Zamora-Ros, M.J. Sánchez, L. Arriola, E. Ardanaz, M.J. Tormo, P. Nilsson, B. Lindkvist, M. Sund, O. Rolandsson, K.T. Khaw, N. Wareham, R.C. Travis, E. Riboli, U. Nöthlings. Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Annals of Oncology 2013; 24(9): 2449 doi: 10.1093/annonc/mdt204
|
| 10 |
Ruth E. Farmer, Deborah Ford, Harriet J. Forbes, Nishi Chaturvedi, Richard Kaplan, Liam Smeeth, Krishnan Bhaskaran. Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation. International Journal of Epidemiology 2016; : dyw275 doi: 10.1093/ije/dyw275
|
| 11 |
Marco Sacco, Davide Giuseppe Ribaldone, Giorgio Maria Saracco. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?. Viruses 2023; 15(12): 2451 doi: 10.3390/v15122451
|
| 12 |
Emmanuel Beck, André J. Scheen. Quels bénéfices antitumoraux attendre de la metformine ?. Annales d'Endocrinologie 2013; 74(2): 137 doi: 10.1016/j.ando.2013.02.009
|
| 13 |
Bhumandeep Kour, Nidhi Shukla, Harshita Bhargava, Devendra Sharma, Amita Sharma, Anjuvan Singh, Jayaraman Valadi, Trilok Chand Sadasukhi, Sugunakar Vuree, Prashanth Suravajhala. Identification of Plausible Candidates in Prostate Cancer Using Integrated
Machine Learning Approaches. Current Genomics 2023; 24(5): 287 doi: 10.2174/0113892029240239231109082805
|
| 14 |
Kazuhisa Kaneda, Takahiro Uenishi, Shigekazu Takemura, Hiroji Shinkawa, Yorihisa Urata, Masayuki Sakae, Takatsugu Yamamoto, Shoji Kubo. The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus‐related hepatocellular carcinoma. Journal of Surgical Oncology 2012; 105(6): 606 doi: 10.1002/jso.22137
|
| 15 |
Abd Elkhalek Hamed. The association between diabetes and liver disease: The need for a consensus. Arab Journal of Gastroenterology 2014; 15(3-4): 166 doi: 10.1016/j.ajg.2014.09.002
|
| 16 |
Jeffrey Nadelson, Sanjaya K. Satapathy, Satheesh Nair. Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis. International Journal of Endocrinology 2016; 2016: 1 doi: 10.1155/2016/8390210
|
| 17 |
Mazen Noureddin, Mary E. Rinella. Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 361 doi: 10.1016/j.cld.2015.01.012
|
| 18 |
Mohsen Janghorbani, Mohsen Dehghani, Mohammad Salehi-Marzijarani. Systematic Review and Meta-analysis of Insulin Therapy and Risk of Cancer. Hormones and Cancer 2012; 3(4): 137 doi: 10.1007/s12672-012-0112-z
|
| 19 |
Hashem B. El-Serag, Fasiha Kanwal. Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?. Hepatology 2014; 60(5): 1767 doi: 10.1002/hep.27222
|
| 20 |
Naoki Yoshida, Yutaka Midorikawa, Tokio Higaki, Hisashi Nakayama, Shingo Tsuji, Shunichi Matsuoka, Hisamitsu Ishihara, Mitsuhiko Moriyama, Tadatoshi Takayama. Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus‐related hepatocellular carcinoma. Hepatology Research 2018; 48(1): 28 doi: 10.1111/hepr.12888
|
| 21 |
Chia‐Ing Li, Hsuan‐Ju Chen, Hsueh‐Chou Lai, Chiu‐Shong Liu, Wen‐Yuan Lin, Tsai‐Chung Li, Cheng‐Chieh Lin. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes––National cohort of Taiwan Diabetes Study. International Journal of Cancer 2015; 136(11): 2668 doi: 10.1002/ijc.29321
|
| 22 |
Stephen C. L. Gough, Cristóbal Belda-Iniesta, Christopher Poole, Matthias Weber, David Russell-Jones, Bo Falck Hansen, Edoardo Mannucci, Jaakko Tuomilehto. Insulin therapy in diabetes and cancer risk: Current understanding and implications for future study. Advances in Therapy 2011; 28(S5): 1 doi: 10.1007/s12325-011-0047-8
|
| 23 |
Paola Loria, Amedeo Lonardo, Frank Anania. Liver and diabetes. A vicious circle. Hepatology Research 2013; 43(1): 51 doi: 10.1111/j.1872-034X.2012.01031.x
|
| 24 |
Hamza Chettouh, Laetitia Fartoux, Lynda Aoudjehane, Dominique Wendum, Audrey Clapéron, Yves Chrétien, Colette Rey, Olivier Scatton, Olivier Soubrane, Filomena Conti, Françoise Praz, Chantal Housset, Olivier Rosmorduc, Christèle Desbois-Mouthon. Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors. Cancer Research 2013; 73(13): 3974 doi: 10.1158/0008-5472.CAN-12-3824
|
| 25 |
Aparna Bhat, Giada Sebastiani, Mamatha Bhat. Systematic review: Preventive and therapeutic applications of metformin in liver disease. World Journal of Hepatology 2015; 7(12): 1652-1659 doi: 10.4254/wjh.v7.i12.1652
|
| 26 |
Laura Mazilu, Dana Stanculeanu, Andreea Gheorghe, Adrian-Paul Suceveanu, Irinel Parepa, Felix Voinea, Doina Catrinoiu, Andra-Iulia Suceveanu. Metformin [Working Title]. 2019; doi: 10.5772/intechopen.88803
|
| 27 |
Takumi Kawaguchi, Eitaro Taniguchi, Minoru Itou, Masahiro Sakata, Shuji Sumie, Michio Sata. Insulin resistance and chronic liver disease. World Journal of Hepatology 2011; 3(5): 99-107 doi: 10.4254/wjh.v3.i5.99
|
| 28 |
Lilian Beatriz Aguayo Rojas, Marilia Brito Gomes. Metformin: an old but still the best treatment for type 2 diabetes. Diabetology & Metabolic Syndrome 2013; 5(1) doi: 10.1186/1758-5996-5-6
|
| 29 |
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70721
|
| 30 |
Saman Bahrambeigi, Bahman Yousefi, Mahdi Rahimi, Vahid Shafiei-Irannejad. Metformin; an old antidiabetic drug with new potentials in bone disorders. Biomedicine & Pharmacotherapy 2019; 109: 1593 doi: 10.1016/j.biopha.2018.11.032
|
| 31 |
Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco. Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?. Digestive and Liver Disease 2016; 48(2): 105 doi: 10.1016/j.dld.2015.10.016
|
| 32 |
Meagan Gray, Sanjeev Singh, Stephen D. Zucker. Influence of Type 2 Diabetes Mellitus and Preoperative Hemoglobin A1c Levels on Outcomes of Liver Transplantation. Hepatology Communications 2019; 3(4): 574 doi: 10.1002/hep4.1323
|
| 33 |
Andrea Casadei Gardini, Giorgia Marisi, Emanuela Scarpi, Mario Scartozzi, Luca Faloppi, Nicola Silvestris, Gianluca Masi, Caterina Vivaldi, Oronzo Brunetti, Stefano Tamberi, Francesco Giuseppe Foschi, Emiliano Tamburini, Elena Tenti, Salvatore Ricca Rosellini, Paola Ulivi, Stefano Cascinu, Oriana Nanni, Giovanni Luca Frassineti. Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib. Expert Opinion on Pharmacotherapy 2015; 16(18): 2719 doi: 10.1517/14656566.2015.1102887
|
| 34 |
Rita Peila, Thomas E. Rohan. Diabetes, Glycated Hemoglobin, and Risk of Cancer in the UK Biobank Study. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(6): 1107 doi: 10.1158/1055-9965.EPI-19-1623
|
| 35 |
Kira Harris, Lisa Smith. Safety and Efficacy of Metformin in Patients With Type 2 Diabetes Mellitus and Chronic Hepatitis C. Annals of Pharmacotherapy 2013; 47(10): 1348 doi: 10.1177/1060028013503108
|
| 36 |
Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Vimal Pandey, Jomon Joseph, Rajashekar Mohan, Praveen Kumar Shetty, Manoj Kumar Bhat. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4. Scientific Reports 2016; 6(1) doi: 10.1038/srep27558
|
| 37 |
Tracey G. Simon, Lindsay Y. King, Dawn Q. Chong, Long H. Nguyen, Yanan Ma, Trang VoPham, Edward L. Giovannucci, Charles S. Fuchs, Jeffrey A. Meyerhardt, Kathleen E. Corey, Hamed Khalili, Raymond T. Chung, Xuehong Zhang, Andrew T. Chan. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology 2018; 67(5): 1797 doi: 10.1002/hep.29660
|
| 38 |
M. Konerman, R. Loomba. Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2015; 42(1): 117 doi: 10.1111/apt.13225
|
| 39 |
Noor Atika Azit, Shahnorbanun Sahran, Leow Voon Meng, Manisekar Subramaniam, Suryati Mokhtar, Azmawati Mohammed Nawi, Yun-Wen Zheng. Risk factors of hepatocellular carcinoma in type 2 diabetes patients: A two-centre study in a developing country. PLOS ONE 2021; 16(12): e0260675 doi: 10.1371/journal.pone.0260675
|
| 40 |
K. H. Williams, N. A. Shackel, M. D. Gorrell, S. V. McLennan, S. M. Twigg. Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo. Endocrine Reviews 2013; 34(1): 84 doi: 10.1210/er.2012-1009
|
| 41 |
Mamatha Bhat, Akiko Yanagiya, Tyson Graber, Nataliya Razumilava, Steve Bronk, Domenick Zammit, Yunhao Zhao, Chadi Zakaria, Peter Metrakos, Michael Pollak, Nahum Sonenberg, Gregory Gores, Maritza Jaramillo, Masahiro Morita, Tommy Alain. Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells. Oncotarget 2017; 8(31): 50542 doi: 10.18632/oncotarget.10671
|
| 42 |
Emily Jane Gallagher, Derek LeRoith. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Annals of the New York Academy of Sciences 2011; 1243(1): 54 doi: 10.1111/j.1749-6632.2011.06285.x
|
| 43 |
Shujuan Ma, Yixiang Zheng, Yanni Xiao, Pengcheng Zhou, Hongzhuan Tan. Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients. Medicine 2017; 96(19): e6888 doi: 10.1097/MD.0000000000006888
|
| 44 |
Edoardo Mannucci. Insulin Therapy and Cancer in Type 2 Diabetes. ISRN Endocrinology 2012; 2012: 1 doi: 10.5402/2012/240634
|
| 45 |
Jian Wang, Tian-yu Chen, Si Qin, Yan Duan, Gang Wang. Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. Medical Hypotheses 2013; 81(5): 805 doi: 10.1016/j.mehy.2013.08.032
|
| 46 |
J C de Beer, L Liebenberg. Does cancer risk increase with HbA1c, independent of diabetes?. British Journal of Cancer 2014; 110(9): 2361 doi: 10.1038/bjc.2014.150
|
| 47 |
Gordon P. Watt, Isela De La Cerda, Jen‐Jung Pan, Michael B. Fallon, Laura Beretta, Rohit Loomba, Miryoung Lee, Joseph B. McCormick, Susan P. Fisher‐Hoch. Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican Americans. Hepatology Communications 2020; 4(12): 1793 doi: 10.1002/hep4.1603
|
| 48 |
Fuming Zi, Huapu Zi, Yi Li, Jingsong He, Qingzhi Shi, Zhen Cai. Metformin and cancer: An existing drug for cancer prevention and therapy (Review). Oncology Letters 2017; doi: 10.3892/ol.2017.7412
|
| 49 |
Li Yin, Zhihui Cai, Baoan Zhu, Cunshuan Xu. Identification of Key Pathways and Genes in the Dynamic Progression of HCC Based on WGCNA. Genes 2018; 9(2): 92 doi: 10.3390/genes9020092
|
| 50 |
Mariusz Dąbrowski, Elektra Szymańska-Garbacz, Zofia Miszczyszyn, Tadeusz Dereziński, Leszek Czupryniak. Risk factors for cancer development in type 2 diabetes: A retrospective case-control study. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2836-6
|
| 51 |
Xu Li, Xiaocong Wang, Pujun Gao. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5202684
|